<DOC>
	<DOCNO>NCT02209415</DOCNO>
	<brief_summary>Follow-up successful operative treatment cancer esophagus , stomach pancreas order detect recurrent disease controversial topic . This method consequence follow patient unknown . Therefore investigator randomize patient two group : 1 . One group patient offer visit specialist surgeon outpatient set clinical evaluation every 3,6,9,12,18 24 month surgery , current standard department . 2 . The group offer Endoscopic UltraSound , EUS , PET/CT interval first group .</brief_summary>
	<brief_title>EUFURO - EUS-based Follow-Up R0-resected Patients Esophageal , Gastric Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>R0 resection primary adenocarcinoma squamous cell carcinoma esophagus , stomach pancreas .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>